📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-26 21:01
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Ravelcare Launches Ravel PRO Range; Reports ~20% Incremental Monthly Revenue Contribution
Ravelcare Limited announced the commercial expansion of its 12-product 'Ravel PRO' haircare range and plans to launch an AI-diagnostic skincare line in H2 FY27. In July 2026, its first full month, Ravel PRO contributed approximately 20% incremental revenue to the company. The company also clarified that its planned backward integration manufacturing capex (funded via Rs 24.10 cr IPO proceeds) has been phased behind product launches, with funds currently held in fixed deposits. For FY26, Ravelcare reported Rs 26.95 cr in revenue (+7.9% YoY) and Rs 5.15 cr in PAT with zero debt.
Confidence: HIGH
What changedRavelcare expanded beyond personalized D2C haircare into ready clinical products on marketplaces/quick-commerce via Ravel PRO, and announced an AI-led skincare entry for H2 FY27.
Why it mattersBroadens total addressable market (TAM) from pure D2C consultations to high-volume omni-channel and quick-commerce retail, providing incremental top-line growth without rising direct acquisition costs.
Ravel PRO Revenue Contribution (1st Month): ~20%Anti-Grey Serum Sales (30 Days): 3,500 unitsFY26 Revenue: Rs 2,695.43 lakhsFY26 PAT: Rs 515.40 lakhsNet IPO Proceeds Raised: Rs 2,191.10 lakhs
📅 Short termPositive initial traction for Ravel PRO on e-commerce and quick commerce should support FY27 top-line growth, with two additional SKUs launching in September.
📈 Long termExpanding into skincare and omnichannel distribution reduces customer acquisition reliance on D2C channels, while eventual in-house manufacturing integration could optimize gross margins.
⚠ Risk flags
- Delay in deploying IPO proceeds towards own manufacturing unit, continuing reliance on third-party manufacturing partners
- High competitive intensity in marketplace and quick-commerce personal care categories
Key Highlights
Ravel PRO delivered ~20% incremental revenue in its first full month (July 2026)
Anti-Grey Serum alone sold about 3,500 units within its first 30 days
AI-diagnostic derma-grade skincare range slated for launch in H2 FY27
IPO proceeds of Rs 2,410.20 lakhs (Rs 2,191.10 lakhs net) for manufacturing capex remain unutilised in bank FDs pending plant scale finalisation
Reported FY26 revenue of Rs 2,695.43 lakhs and PAT of Rs 515.40 lakhs with zero debt
👀 What to Watch
Track quarterly revenue acceleration from Ravel PRO across marketplaces and quick-commerce channels, as well as the updated timeline for manufacturing plant deployment.
